- Home
- REG vs NARI Comparison
REG vs NARI Comparison
Compare REG & NARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REG
- NARI
- Stock Information
- Founded
- REG 1963
- NARI 2011
- Country
- REG United States
- NARI United States
- Employees
- REG N/A
- NARI N/A
- Industry
- REG Real Estate Investment Trusts
- NARI Medical/Dental Instruments
- Sector
- REG Real Estate
- NARI Health Care
- Exchange
- REG Nasdaq
- NARI Nasdaq
- Market Cap
- REG N/A
- NARI 2.6B
- IPO Year
- REG 1993
- NARI 2020
- Fundamental
- Price
- REG $74.97
- NARI $45.81
- Analyst Decision
- REG Strong Buy
- NARI Buy
- Analyst Count
- REG 11
- NARI 9
- Target Price
- REG $75.09
- NARI $59.86
- AVG Volume (30 Days)
- REG 895.4K
- NARI 865.4K
- Earning Date
- REG 10-31-2024
- NARI 10-30-2024
- Dividend Yield
- REG 3.59%
- NARI N/A
- EPS Growth
- REG N/A
- NARI N/A
- EPS
- REG 2.09
- NARI N/A
- Revenue
- REG $1,459,214,000.00
- NARI $547,474,000.00
- Revenue This Year
- REG N/A
- NARI $24.01
- Revenue Next Year
- REG $3.46
- NARI $18.41
- P/E Ratio
- REG $35.79
- NARI N/A
- Revenue Growth
- REG 13.56
- NARI 24.67
- 52 Week Low
- REG $56.29
- NARI $36.73
- 52 Week High
- REG $75.26
- NARI $69.40
- Technical
- Relative Strength Index (RSI)
- REG 71.24
- NARI 52.26
- Support Level
- REG $73.44
- NARI $43.85
- Resistance Level
- REG $75.26
- NARI $47.03
- Average True Range (ATR)
- REG 1.04
- NARI 1.96
- MACD
- REG 0.04
- NARI 0.52
- Stochastic Oscillator
- REG 90.36
- NARI 92.73
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.